Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease. Gente K, Feisst M, Marx D, Klika KD, et al. Ann Rheum Dis 2024;83:974-983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gente K, Feisst M, Marx D, Klika KD, et al. Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease. Ann Rheum Dis 2024;83:974-983.
PMID: 38561219